Home
Glaukos

Glaukos Market Share Analysis for April 2026

Glaukos is an ophthalmic medical technology and pharmaceutical company focused on therapies for treatment of glaucoma, corneal disorders, and retinal diseases.

Health > Health - Other

Domainglaukos.com

Year Founded1998

Employees1001 - 5000

Annual Revenue$200M - $500M

Glaukos

Glaukos (including company regionals)

glaukos.com

See more website traffic and engagement information

Glaukos Revenue up to April 2026 is 200M - 500M

revenue generated by Glaukos top domains

Glaukos top domains revenue over 3 years

Revenue for Glaukos top domains

glaukos.com200M - 500M

See more with Sales Intelligence

Total visits to Glaukos's top domains

Understand Glaukos market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

glaukos.com28.3K

See more with Sales Intelligence

Avg. visit duration in Glaukos's top domains

Analyze Glaukos engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

glaukos.com00:00:27

See more with Sales Intelligence

Avg. pageviews on Glaukos's top domains

See how Glaukos keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

glaukos.com1.76

See more with Sales Intelligence

Glaukos top competitors by domain

Top similar sites in April 2026, ranked by their affinity

bvimedical.comCompany NameBVI MedicalEmployees1001 - 5000HQUnited States, Massachusetts, WalthamAnnual revenue$200M - $500MTotal visits29.3KHealth > Health - Other

Top technologies used by Glaukos

These are the website technologies, by industry, used by Glaukos top domains

Advertising (14)

DoubleClick

Conversion & Analytics (7)

Google Analytics

Payment & Currencies (5)

PayPal

Widget (5)

Twemoji

More Technologies

13

See all

News & Signals from Glaukos

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGlaukos Corporation attends event ASCRS 2026.Glaukos to Showcase innovative ophthalmic technologies at ASCRS 2026.

NewsGlaukos Corporation had revenue of $129M on Jan 1st '26.Glaukos also announced that its glaucoma net sales reached a record $129.3 million during the first quarter of 2026, representing a 47 percent year-over-year growth.

NewsGlaukos Corporation signs new client CMS.Glaukos Corporation announced the U.S. Centers for Medicare and Medicaid Services (CMS) has assigned a unique, permanent Healthcare Common Procedure Coding System (HCPCS) J-code for Epioxa(TM) HD/Epioxa(TM)("Epioxa") for the treatment of keratoconus.